New Jersey A 4923: Requires converting portion of Paramus and Menlo Park veterans' memorial homes into single occupancy rooms; requires upgrades to ventilation systems; provides Adjutant General discretion for additional room considerations.*

Bill Text

A4923 

ASSEMBLY, No. 4923 

STATE OF NEW JERSEY

222nd LEGISLATURE

� 

INTRODUCED MAY 7, 2026

Sponsored by:

Assemblyman� KENYATTA STEWART

District 35 (Bergen and Passaic)

SYNOPSIS

���� Creates grant program in DOH to increase early 
detection of and intervention for uterine fibroids; appropriates $5 million. 

CURRENT VERSION OF TEXT 

���� As introduced.

�� 

An Act concerning uterine fibroids, supplementing Title 26 of 
the Revised Statutes, and making an appropriation. 

���� Be It 
Enacted by the Senate and General Assembly of 
the State of New Jersey:

���� 1.��� The Commissioner of 
Health, in consultation with the Commissioner of Banking and Insurance, shall 
evaluate and recommend policies to the Governor, and pursuant to section 2 of 
P.L.1991, s.164 (C.52:14-19.1), the Legislature within one calendar year of the 
date of enactment of this act which ensure coverage for uterine fibroid 
screening and treatment under State-regulated health plans. 

���� 2.��� a. The Commissioner of 
Health shall establish a grant program to support research on increasing early 
detection of, and intervention for, uterine fibroids, and based on the results 
of such research and other relevant information, formulate evidence-based or 
evidence-informed strategies to increase early detection of uterine fibroids in 
health care settings.� The commissioner, within 90 days of the effective date 
of this act, shall establish an application process for grants awarded pursuant 
to subsections b. and d. of this section, including provisions for the 
submission of a report one year following the disbursement of funds to the 
grant recipient and which report shall include a summary on the use of grant 
funds, tracking requirements pursuant to subsection e. of this section, and any 
results or conclusions drawn from the use of the funds, for organizations to 
apply for grant monies appropriated for the purposes of this act. 

���� b.��� The commissioner shall 
distribute grant money, subject to the availability of funds, for organizations 
that:

���� (1)�� research early detection 
of and intervention for uterine fibroids; and 

���� (2)�� develop and implement 
public awareness campaigns for the early detection of and intervention for uterine 
fibroids. 

���� c.���� Within 27 months of the 
grant monies disbursed pursuant to subsection b. of this section, the 
commissioner shall:� (1) establish and formulate evidence-based or 
evidence-informed strategies, informed by the results of the research reported 
by grant recipients pursuant to subsection b. of this act, to increase early 
detection of uterine fibroids in health care settings; and (2) develop 
education materials and training programs for health care providers on early 
detection and treatment of uterine fibroids.� These strategies, materials, and 
programs shall be annually reviewed and updated as needed, and will be utilized 
to inform grants awarded pursuant to subsection d. of this section.

���� d.��� The commissioner shall 
additionally distribute grant money, subject to the availability of funds, to 
organizations for the following activities:

���� (1)�� screening procedures, 
including advanced gynecological imaging and payment thereof;

���� (2)�� patient navigation 
services; 

���� (3)�� implementation of 
evidence-based or evidence-informed strategies proven to increase early 
detection of uterine fibroids in health care settings; 

���� (4)�� facilitate access to 
health care settings; 

���� (5)�� research, including 
clinical research trials, related to disparities in pain control and management 
in uterine fibroid surgical treatment; and 

���� (6)�� research, including 
clinical research trials, related to Asherman�s Syndrome, intrauterine 
adhesions, and other intrauterine conditions as determined appropriate by the 
commissioner. 

���� In awarding grants under this 
act, the commissioner shall give priority to organizations applying in 
partnership with community-based organizations. 

���� e.���� Grant recipients shall 
track:

���� (1)�� screening rates; 

���� (2)�� early diagnosis rates; 

���� (3)�� reduction in late-stage 
complications; and 

���� (4)�� patient outcomes. 

���� f.���� Within one year and 
annually thereafter, the commissioner shall submit a report to the Governor, 
and pursuant to section 2 of P.L.1991, c.164 (C.52:14-19.1), to the Legislature 
detailing the grant recipients and the activities for which the money was awarded.� 
As reports from grant recipients pursuant to this act become available, the 
commissioner shall also include a summary of such reports received in the 
calendar year prior to the submission deadline of this report to the Governor 
and the Legislature.� The commissioner shall, upon request by the Governor or a 
member of the Legislature, may make available any original report submitted by 
a grant recipient, and may publish such reports on the Department of Health 
website. 

���� 3.��� There